Search

everythinglearnresearchcommunity

for

Search:↓

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

Men with systemic lupus erythematosus often have more severe symptoms but can respond well to treatment.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Regular monitoring of autoantibodies in ANA-positive patients with hair loss helps detect and treat lupus early.

Early treatment of mixed connective tissue disease is crucial to prevent severe autoimmune conditions.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Methotrexate is effective for rheumatoid arthritis but can cause side effects.

Anti-Ro exposed children had more reported neuro-psychiatric issues, but differences from healthy controls were not significant.

People with ankylosing spondylitis in Taiwan don't have a higher chance of getting alopecia.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

SLE can occur in young males and cause knee pain.

A woman's hair grew back while she was taking sulphasalazine for arthritis.

Belimumab effectively reduces disease activity in lupus patients, regardless of initial serologic status.

Most women with ankylosing spondylitis tested positive for HLA-B27, suggesting it's useful for diagnosis.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

It's unclear if COVID-19 vaccination causes SLE; more research is needed.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Psoriasis patients have more comorbidities, including autoimmune diseases and other health issues, than those without psoriasis.

Rash in SLE patients indicates more severe disease.